Acute Cardiovascular Effects of Sibutramine in Conscious Rats

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2004-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1124/JPET.103.061259PMID 14634034
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanical behavior of pressurized in vitro prearteriolar vessels determined with a video system

  2006cited by this paper
• Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients

  2005cited by this paper
• Effect on radiolabelled-monoamine uptake in vitro of plasma taken from healthy volunteers administered the antidepressant sibutramine HCl

  2005cited by this paper
• Selective Impairment in Sympathetic Vasomotor Control With Norepinephrine Transporter Inhibition

  2003cited by this paper
• Probing conformational changes in neurotransmitter transporters: a structural context.

  2003cited by this paper
• Complex regional haemodynamic effects of anandamide in conscious rats

  2002cited by this paper
• Paradoxical Effect of Sibutramine on Autonomic Cardiovascular Regulation

  2002influential reference
• Selective Norepinephrine Reuptake Inhibition as a Human Model of Orthostatic Intolerance

  2002cited by this paper
• Mechanism of suppression of insulin signalling with lignocaine

  2002cited by this paper
• The discovery and status of sibutramine as an anti-obesity drug.

  2002cited by this paper
• Anti-obesity drugs: a critical review of current therapies and future opportunities.

  2001cited by this paper
• Vascular adrenoceptors: an update.

  2001cited by this paper
• Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus

  2000cited by this paper
• Obesity as a medical problem

  2000cited by this paper
• Comparison of the effects of sibutramine and other weight‐modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats

  2000cited by this paper
• Thermogenic effects of sibutramine and its metabolites

  1999cited by this paper
• Sibutramine pharmacokinetics in young and elderly healthy subjects

  1999cited by this paper
• Remodelling and Enhanced Myogenic Tone in Cerebral Resistance Arteries Isolated from Genetically Hypertensive Brattleboro Rats

  1998cited by this paper
• Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake.

  1998cited by this paper
• Sibutramine: a review of the pharmacology of a novel anti-obesity agent.

  1997cited by this paper
• Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat

  1997influential reference
• THE PHARMACOLOGY OF SIBUTRAMINE, THE FIRST SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR TO BE DEVELOPED FOR THE TREATMENT OF OBESITY

  1997cited by this paper
• [3H]nisoxetine--a radioligand for noradrenaline reuptake sites: correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments.

  1996cited by this paper
• Vascular structure in hypertension induced by NG-nitro-L-arginine methyl ester: methodological considerations for studies of small arteries in hypertension--reply.

  1995cited by this paper
• Regional adiposity and morbidity.

  1994cited by this paper
• Regional haemodynamic effects of angiotensin II (3–8) in conscious rats

  1993cited by this paper
• Mechanisms contributing to the differential haemodynamic effects of bombesin and cholecystokinin in conscious, Long Evans rats

  1991cited by this paper
• Effects of NG‐nitro‐l‐arginine methyl ester on vasodilator responses to acetylcholine, 5′‐N‐ethylcarboxamidoadenosine or salbutamol in conscious rats

  1991cited by this paper
• Antagonistic effect of human α-CGRP [8–37] on the in vivo regional haemodynamic actions of human α-CGRP

  1990cited by this paper
• The contribution of metabolites to the rapid and potent down-regulation of rat cortical beta-adrenoceptors by the putative antidepressant sibutramine hydrochloride.

  1989cited by this paper
• Regional hemodynamic responses to adrenoceptor antagonism in conscious rats.

  1988cited by this paper
• Clinical pharmacology of sibutramine hydrochloride (BTS 54524), a new antidepressant, in healthy volunteers.

  1988cited by this paper
• Friedman and Quade tests: BASIC computer program to perform nonparametric two-way analysis of variance and multiple comparisons on ranks of several related samples.

  1987cited by this paper
• Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

  1972cited by this paper

• Monitoring haemodynamic changes in rodent models to better inform safety pharmacology: Novel insights from in vivo studies and waveform analysis

  2022influential citation
• Assessment of redox state and biochemical parameters of salivary glands in rats treated with anti-obesity drug sibutramine hydrochloride

  2022cites this paper
• Active Pharmaceutical Contaminants in Dietary Supplements: a Tier-Based Risk Assessment Approach.

  2021cites this paper
• Validation of the method for determination of Phenolphthalein and Sibutramine in weight‐loss functional foods from Viet Nam by UPLC‐MS/MS

  2021cites this paper
• Effects of 4 multitargeted receptor tyrosine kinase inhibitors on regional hemodynamics in conscious, freely moving rats

  2016cites this paper
• infusion in conscious rats regional hemodynamic responses to lipopolysaccharide

  2016cites this paper
• Tracers for Sympathetic Cardiac Neurotransmission Imaging

  2015cites this paper
• High-Fat Diet-Induced Alterations in the Feeding Suppression of Low-Dose Nisoxetine, a Selective Norepinephrine Reuptake Inhibitor

  2013cites this paper
• Posible mecanismo involucrado en el efecto vasodilatador inducido por fenproporex en anillos aórticos de rata

  2013cites this paper
• Sibutramine for the treatment of recurrent high-flow priapism.

  2012cites this paper
• Possible involvement of GLP‐1(9–36) in the regional haemodynamic effects of GLP‐1(7–36) in conscious rats

  2010cites this paper
• 5‐HT1A Activation Counteracts Cardiovascular But Not Hypophagic Effects of Sibutramine in Rats

  2009cites this paper
• Simultaneous determination of anti-diabetes/anti-obesity drugs by LC/PDA, and targeted analysis of sibutramine analog in dietary supplements by LC/MS/MS.

  2009cites this paper
• Autonomic nervous system‐dependent and ‐independent cardiovascular effects of exendin‐4 infusion in conscious rats

  2008cites this paper
• The Triple Uptake Inhibitor (1R,5S)-(+)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0] Hexane Hydrochloride (DOV 21947) Reduces Body Weight and Plasma Triglycerides in Rodent Models of Diet-Induced Obesity

  2008cites this paper
• Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation

  2006cites this paper
• Mesenteric Vasoconstriction and Hindquarters Vasodilatation Accompany the Pressor Actions of Exendin-4 in Conscious Rats

  2006cites this paper
• Involvement of CB1-receptors and beta-adrenoceptors in the regional hemodynamic responses to lipopolysaccharide infusion in conscious rats.

  2005cites this paper
• Regional Hemodynamic Effects of the N-(2-Benzoylphenyl)-l-tyrosine Peroxisome Proliferator-Activated Receptor-γ Ligand, GI 262570 [(S)-2-(2-Benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyl-2-oxazol-4-yl)ethoxy]phenyl]propionic Acid], in Conscious Rats

  2004cites this paper
• Autonome, kardiovaskuläre und metabolische Wirkungen kombinierter pharmakologischer Noradrenalin- und Serotonin-Wiederaufnahme-Hemmung

  2004cites this paper